Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
- Written by Newsfile
Boston, Massachusetts--(Newsfile Corp. - August 15, 2023) - Here at Horizon Insights, we see two big trends right now in healthcare - the emergence of Artificial Intelligence, or AI platforms, and the growing prevalence and acceptance of Telehealth. Ainos, Inc. (NASDAQ: AIMD), a diversified healthcare company that develops novel point-of-care testing (POCT) medical diagnostic devices and therapeutic drug candidates for treating various diseases, is developing products incorporating both these trends into one device. Ainos has developed a technology called AI Nose designed to identify Volatile Organic Compounds (VOC), and we see this as potentially revolutionary for the future of healthcare.
To view the full announcement, including downloadable images, bios, and more, click here[1].
Key Takeaways:
- Horizon Insights, we see two big trends right now in healthcare - the emergence of Artificial Intelligence, or AI platforms, and the growing prevalence and acceptance of Telehealth.
- With the increasing rate of global infections such as COVID and influenza, consumers are becoming increasingly more comfortable with self-testing and the use of telehealth, and applications of AI-based algorithms to advance the standard of care, in healthcare and beyond.
Click image above to view full announcement.
Important Disclosures
Horizon Insights ("Horizon") is a team of former buy-side, sell-side, and investment banking analysts. A member of the Horizon team prepared this report. Horizon hereby certifies that the views expressed in this report accurately reflect the personal views about the subject securities and issuers. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the recommendations or views expressed in this report. We believe the information used to create this report has been obtained from sources considered reliable. Still, Horizon can neither guarantee nor represent the completeness or accuracy of the information herewith. Such information and the opinions expressed are subject to change without notice. Because of individual financial or investment objectives and/or financial circumstances, this report or article should not be construed as advice designed to meet the particular investment needs of any investor. Investing involves risk. Any opinions expressed by Horizon are subject to change without notice. Reports or articles, or tweets are not to be construed as an offer or solicitation of an offer to buy or sell the securities herein mentioned.
INVESTMENT BANKING AND FEES FOR SERVICES
Horizon has not received compensation for investment banking services from the issuers of the securities covered in this report or article. Horizon has received compensation from the issuer directly, from an investment manager, or from a third party to engaged by the issuer for providing non-investment banking services to this issuer, which includes the preparation of this report, investor relations services, and consultancy on business development and overall corporate strategy. Horizon expects to receive additional compensation for such services provided to this issuer in the future. The fees for these services vary on a per-client basis and are subject to the number and types of services contracted.
Contacts:
HAIZHANG WEIhwey@horizonconsultancy.co[2]
Source: Horizon Insights[3]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177345[4]
References
- ^ click here (api.newsfilecorp.com)
- ^ hwey@horizonconsultancy.co (www.newsfilecorp.com)
- ^ Horizon Insights (api.newsfilecorp.com)
- ^ https://www.newsfilecorp.com/release/177345 (api.newsfilecorp.com)